Literature DB >> 29068607

Relationship between toxoplasmosis and schizophrenia: A review.

Aleksander J Fuglewicz1, Patryk Piotrowski2, Anna Stodolak1.   

Abstract

A growing body of evidence suggests a correlation between schizophrenia and exposure to infectious agents. The majority of studied cases concerns the infection caused by T. gondii, an obligatory intracellular parasite that infects about 1/3 of the entire human population, according to the available data. The acute stage of the disease, predominantly short-lived and transient, transforms into the latent and chronic phase in which the parasite localizes within tissue cysts, mainly in the central nervous system. The chronic toxoplasmosis, primarily regarded as benign and asymptomatic, might be responsible, in light of current scientific evidence, for a vast array of neuropsychiatric symptoms. Numerous epidemiological case-control studies show a higher prevalence of T. gondii infestation in individuals with various psychiatric and behavior disorders, including schizophrenia. This paper tends to review the relevant studies that demonstrate links between schizophrenia and T. gondii infestation, of which the latter may be acquired in different developmental phases. Apart from epidemiological correlation studies, some papers on other associations were also presented, describing putative patophysiological mechanisms that might be at least partly responsible for chronic infection-induced neuromediator disturbances, together with morphological and functional alterations, e.g., low-grade neuroinflammation, which are likely to induce psychopathological symptoms. Toxoplasmosis is only one of the putative infectious agents that derange correct brain growth and differentiation, alongside genetic and environmental factors. All of them may lead eventually to schizophrenia. A better knowledge of infection mechanisms and its influence on neurobiochemical and neuropathological pathways may enable more efficient therapy and the prevention of this devastating disease.

Entities:  

Keywords:  Toxoplasma gondii; neuropsychiatric symptoms; schizophrenia

Mesh:

Substances:

Year:  2017        PMID: 29068607     DOI: 10.17219/acem/61435

Source DB:  PubMed          Journal:  Adv Clin Exp Med        ISSN: 1899-5276            Impact factor:   1.727


  26 in total

Review 1.  Toxoplasma gondii infection and behavioral outcomes in humans: a systematic review.

Authors:  Victor Otero Martinez; Fernanda Washington de Mendonça Lima; Chrissie Ferreira de Carvalho; José Antônio Menezes-Filho
Journal:  Parasitol Res       Date:  2018-08-14       Impact factor: 2.289

2.  Discovery and Optimization of Triazine Nitrile Inhibitors of Toxoplasma gondii Cathepsin L for the Potential Treatment of Chronic Toxoplasmosis in the CNS.

Authors:  Jeffery D Zwicker; David Smith; Alfredo J Guerra; Jacob R Hitchens; Nicole Haug; Steve Vander Roest; Pil Lee; Bo Wen; Duxin Sun; Lu Wang; Richard F Keep; Jianming Xiang; Vern B Carruthers; Scott D Larsen
Journal:  ACS Chem Neurosci       Date:  2020-02-18       Impact factor: 4.418

3.  Evaluation of ATM Kinase Inhibitor KU-55933 as Potential Anti-Toxoplasma gondii Agent.

Authors:  Jonathan Munera López; Agustina Ganuza; Silvina S Bogado; Daniela Muñoz; Diego M Ruiz; William J Sullivan; Laura Vanagas; Sergio O Angel
Journal:  Front Cell Infect Microbiol       Date:  2019-02-13       Impact factor: 5.293

4.  Schizophrenia and Bartonella spp. Infection: A Pilot Case-Control Study.

Authors:  Erin Lashnits; Ricardo Maggi; Fredrik Jarskog; Julie Bradley; Edward Breitschwerdt; Flavio Frohlich
Journal:  Vector Borne Zoonotic Dis       Date:  2021-03-15       Impact factor: 2.523

5.  Mind Control: How Parasites Manipulate Cognitive Functions in Their Insect Hosts.

Authors:  Frederic Libersat; Maayan Kaiser; Stav Emanuel
Journal:  Front Psychol       Date:  2018-05-01

6.  Two old drugs, NVP-AEW541 and GSK-J4, repurposed against the Toxoplasma gondii RH strain.

Authors:  Shuxian Liu; Mimi Wu; Qianqian Hua; Daiqiang Lu; Yuan Tian; Helin Yu; Linyan Cheng; Yinqi Chen; Jiaxin Cao; Xin Hu; Feng Tan
Journal:  Parasit Vectors       Date:  2020-05-11       Impact factor: 3.876

Review 7.  Early Senescence and Leukocyte Telomere Shortening in SCHIZOPHRENIA: A Role for Cytomegalovirus Infection?

Authors:  Corona Solana; Diana Pereira; Raquel Tarazona
Journal:  Brain Sci       Date:  2018-10-18

8.  QuilA-Adjuvanted T. gondii Lysate Antigens Trigger Robust Antibody and IFNγ+ T Cell Responses in Pigs Leading to Reduction in Parasite DNA in Tissues Upon Challenge Infection.

Authors:  Mizanur Rahman; Bert Devriendt; Ignacio Gisbert Algaba; Bavo Verhaegen; Pierre Dorny; Katelijne Dierick; Eric Cox
Journal:  Front Immunol       Date:  2019-09-20       Impact factor: 7.561

Review 9.  Antimalarial Agents as Therapeutic Tools Against Toxoplasmosis-A Short Bridge between Two Distant Illnesses.

Authors:  Alina Secrieru; Inês C C Costa; Paul M O'Neill; Maria L S Cristiano
Journal:  Molecules       Date:  2020-03-30       Impact factor: 4.411

Review 10.  Toxoplasmosis: Overview from a One Health perspective.

Authors:  Olgica Djurković-Djaković; Jean Dupouy-Camet; Joke Van der Giessen; Jitender P Dubey
Journal:  Food Waterborne Parasitol       Date:  2019-04-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.